Annexon Biosciences Financial Overview
Annexon Biosciences's market cap is currently $748.25M. The company's EPS TTM is $-0.37; its P/E ratio is -3.67; Annexon Biosciences is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
